Data gathered: November 22
Alternative Data for DarioHealth
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 2 | Sign up | Sign up | Sign up |
| Sentiment | 74 | Sign up | Sign up | Sign up |
| Webpage traffic | 18,000 | Sign up | Sign up | Sign up |
| Employee Rating | 62 | Sign up | Sign up | Sign up |
| Google Trends | 92 | Sign up | Sign up | Sign up |
| Patents | 1 | Sign up | Sign up | Sign up |
| App Downloads | 13 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 9 | Sign up | Sign up | Sign up |
| Facebook Followers | 70,436 | Sign up | Sign up | Sign up |
| Instagram Followers | 7,610 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 2 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 3,597 | Sign up | Sign up | Sign up |
| Twitter Followers | 8,255 | Sign up | Sign up | Sign up |
| Twitter Mentions | 105 | Sign up | Sign up | Sign up |
| Youtube Subscribers | 1,760 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 40 | Sign up | Sign up | Sign up |
| Linkedin Employees | 243 | Sign up | Sign up | Sign up |
About DarioHealth
DarioHealth Corp. operates as a digital therapeutics company in the United States, Canada, the European Union, Australia, and New Zealand.
| Price | $0.83 |
| Target Price | Sign up |
| Volume | 12,890 |
| Market Cap | $28M |
| Year Range | $0.77 - $1.9 |
| Dividend Yield | 0% |
| Analyst Rating | 100% buy |
| Industry | Biotechnology |
In the news
 |
DarioHealth secures four new employer contracts for 2025November 21 - Investing.com |
 |
DarioHealth Third Quarter 2024 Earnings: EPS Beats ExpectationsNovember 8 - Yahoo |
 |
DarioHealth Corp. (DRIO) Q3 2024 Earnings Call TranscriptNovember 8 - SeekingAlpha |
 |
DarioHealth Corp (DRIO) Q3 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ...November 7 - Yahoo |
 |
DarioHealth Corp. (DRIO) Reports Q3 Loss, Tops Revenue EstimatesNovember 6 - Yahoo |
 |
DarioHealth Reports Third Quarter 2024 Financial and Operating ResultsNovember 6 - Yahoo |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '24 | 7.4M | 14M | 3.9M | -12M | -10M | -0.250 |
| Q2 '24 | 6.3M | 16M | 2.8M | -14M | -15M | -0.080 |
| Q1 '24 | 5.8M | 18M | 2.4M | -7.2M | -17M | -0.200 |
| Q4 '23 | 2.9M | 16M | 130,000 | -14M | -13M | -0.500 |
| Q3 '23 | 3.5M | 13M | 610,000 | -16M | -14M | -0.490 |
Insider Transactions View All
| Nelson Steven Charles filed to buy 50,000 shares at $0.8. September 12 '24 |
| Nelson Steven Charles filed to buy 40,000 shares at $0.8. September 10 '24 |
| Raphael Erez filed to buy 1,937,059 shares at $0.9. August 28 '24 |
| Nelson Steven Charles filed to buy 25,000 shares at $0.9. August 23 '24 |
| Raphael Erez filed to buy 1,932,059 shares at $1. August 23 '24 |
Similar companies
Read more about DarioHealth (DRIO) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, app downloads, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of DarioHealth?
The Market Cap of DarioHealth is $28M.
What is the current stock price of DarioHealth?
Currently, the price of one share of DarioHealth stock is $0.83.
How can I analyze the DRIO stock price chart for investment decisions?
The DRIO stock price chart above provides a comprehensive visual representation of DarioHealth's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling DarioHealth shares. Our platform offers an up-to-date DRIO stock price chart, along with technical data analysis and alternative data insights.
Does DRIO offer dividends to its shareholders?
As of our latest update, DarioHealth (DRIO) does not offer dividends to its shareholders. Investors interested in DarioHealth should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of DarioHealth?
Some of the similar stocks of DarioHealth are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
.